PHARMAIDS PHARMACEUTICALS LTD. has revised their statement of nil deviation(s) or variation(s) of funds under Regulation 32 for the quarter ended June 30, 2023, rectifying an incorrect figure in the previous disclosure.
AI Assistant
Pharmaids Pharmaceuticals Ltd
2023
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.